Chartwell Investment Partners’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-41,190
Closed -$1.29M 427
2022
Q2
$1.29M Sell
41,190
-13,829
-25% -$501K 0.05% 328
2022
Q1
$2.42M Buy
55,019
+2,304
+4% +$98.9K 0.08% 273
2021
Q4
$2.29M Sell
52,715
-993
-2% -$38.9K 0.07% 289
2021
Q3
$1.68M Hold
53,708
0.05% 321
2021
Q2
$2.27M Buy
53,708
+485
+0.9% +$18.9K 0.07% 279
2021
Q1
$2M Sell
53,223
-32,630
-38% -$1.02M 0.06% 286
2020
Q4
$2.32M Buy
85,853
+53,976
+169% +$1.39M 0.07% 265
2020
Q3
$800K Buy
+31,877
New +$465K 0.03% 369

Other funds holding ACH

Chartwell Investment Partners's ACH Position: Q3 2022 in Review

Chartwell Investment Partners sold out of Accendra Health (ACH) in Q3 2022, closing a stake of 41,190 shares — an estimated $1.29M sold.

Chartwell Investment Partners first reported a position in ACH in Q3 2020 and held it in 8 quarters. The position peaked at $2.42M in Q1 2022. 227 funds tracked by Wall St. Rank hold ACH as of Q3 2022.

  • Chartwell Investment Partners reported no remaining Accendra Health position as of Q3 2022 after selling out during the quarter.
  • Chartwell Investment Partners sold 41,190 Accendra Health shares in Q3 2022, an estimated $1.29M.
  • Chartwell Investment Partners first reported a position in Accendra Health in Q3 2020 and held it in 8 quarters.
  • Chartwell Investment Partners's Accendra Health position peaked at $2.42M in Q1 2022.
  • 227 funds tracked by Wall St. Rank held Accendra Health as of Q3 2022.

Based on Chartwell Investment Partners's 13F filing for Q3 2022, filed 27 Oct 2022.